Bristol-Myers Squibb de Mexico S. de R. L. de C.V. Sustainability Profile
Bristol-Myers Squibb de Mexico S. de R. L. de C.V., a subsidiary of the global biopharmaceutical leader Bristol-Myers Squibb, is headquartered in Mexico (MX) and operates extensively across the region. Founded in the early 2000s, the company has established itself within the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, immunology, and cardiovascular health. Bristol-Myers Squibb de Mexico is renowned for its commitment to research and development, offering unique therapies that address unmet medical needs. With a strong market position, the company has achieved significant milestones, including the launch of groundbreaking treatments that have transformed patient care. Its dedication to advancing healthcare in Mexico underscores its role as a key player in the biopharmaceutical sector.
DitchCarbon Score
How does Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s score of 68 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bristol-Myers Squibb de Mexico S. de R. L. de C.V. currently does not report specific carbon emissions data for the latest year, as no emissions figures are available. However, the company is part of a broader corporate family that includes Bristol-Myers Squibb Company, which has established significant climate commitments and reduction initiatives. As a current subsidiary of Bristol-Myers Squibb Company, emissions data and climate targets are cascaded from this parent organisation. Bristol-Myers Squibb Company has set ambitious science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets encompass Scope 1, 2, and 3 emissions, reflecting a comprehensive approach to climate action. While specific reduction targets for Bristol-Myers Squibb de Mexico are not detailed, the overarching commitments from the parent company indicate a strong focus on sustainability and emissions reduction. The company is actively engaged in initiatives such as the Carbon Disclosure Project (CDP) and the RE100 initiative, which aims for 100% renewable electricity. In summary, while Bristol-Myers Squibb de Mexico S. de R. L. de C.V. does not currently report specific emissions data, it benefits from the climate commitments and reduction strategies of its parent company, Bristol-Myers Squibb Company, which are designed to drive significant progress in reducing carbon emissions across its global operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 210,540,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 150,790,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 69,630,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s Industry?
How Carbon Intensive is Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s Location?
Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s Scope 3 Categories Breakdown
Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s Scope 3 emissions, which decreased by 1% last year and increased significantly since 2015, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 77% of Scope 3 emissions.
Top Scope 3 Categories
Bristol-Myers Squibb de Mexico S. de R. L. de C.V.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bristol-Myers Squibb de Mexico S. de R. L. de C.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
